These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 31390156)
1. Differential Responsiveness of Monocyte and Macrophage Subsets to Interferon. Han S; Zhuang H; Lee PY; Li M; Yang L; Nigrovic PA; Reeves WH Arthritis Rheumatol; 2020 Jan; 72(1):100-113. PubMed ID: 31390156 [TBL] [Abstract][Full Text] [Related]
2. NF-E2-Related Factor 2 Regulates Interferon Receptor Expression and Alters Macrophage Polarization in Lupus. Han S; Zhuang H; Lee PY; Li M; Yang L; Nigrovic PA; Reeves WH Arthritis Rheumatol; 2020 Oct; 72(10):1707-1720. PubMed ID: 32500632 [TBL] [Abstract][Full Text] [Related]
3. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility. Aue A; Szelinski F; Weißenberg SY; Wiedemann A; Rose T; Lino AC; Dörner T Rheumatology (Oxford); 2020 Nov; 59(11):3435-3442. PubMed ID: 32357246 [TBL] [Abstract][Full Text] [Related]
4. Virgin olive oil and its phenol fraction modulate monocyte/macrophage functionality: a potential therapeutic strategy in the treatment of systemic lupus erythematosus. Aparicio-Soto M; Montserrat-de la Paz S; Sanchez-Hidalgo M; Cardeno A; Bermudez B; Muriana FJG; Alarcon-de-la-Lastra C Br J Nutr; 2018 Sep; 120(6):681-692. PubMed ID: 30060774 [TBL] [Abstract][Full Text] [Related]
6. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus. Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555 [TBL] [Abstract][Full Text] [Related]
7. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus. Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863 [TBL] [Abstract][Full Text] [Related]
8. High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass Cytometry. Yiu G; Rasmussen TK; Tsai BL; Diep VK; Haddon DJ; Tsoi J; Miller GD; Comin-Anduix B; Deleuran B; Crooks GM; Utz PJ Front Immunol; 2022; 13():833636. PubMed ID: 35185925 [TBL] [Abstract][Full Text] [Related]
9. The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells. Pogue SL; Preston BT; Stalder J; Bebbington CR; Cardarelli PM J Interferon Cytokine Res; 2004 Feb; 24(2):131-9. PubMed ID: 14980077 [TBL] [Abstract][Full Text] [Related]
11. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells. Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of mTOR suppresses IFNα production and the STING pathway in monocytes from systemic lupus erythematosus patients. Murayama G; Chiba A; Kuga T; Makiyama A; Yamaji K; Tamura N; Miyake S Rheumatology (Oxford); 2020 Oct; 59(10):2992-3002. PubMed ID: 32160289 [TBL] [Abstract][Full Text] [Related]
13. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference? Kyogoku C; Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Häupl T; Hiepe F; Alexander T; Radbruch A; Grützkau A PLoS One; 2013; 8(12):e83776. PubMed ID: 24391825 [TBL] [Abstract][Full Text] [Related]
15. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity. Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145 [TBL] [Abstract][Full Text] [Related]
16. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy. Lesinski GB; Kondadasula SV; Crespin T; Shen L; Kendra K; Walker M; Carson WE J Natl Cancer Inst; 2004 Sep; 96(17):1331-42. PubMed ID: 15339971 [TBL] [Abstract][Full Text] [Related]
17. An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential. Hadj-Slimane R; Chelbi-Alix MK; Tovey MG; Bobé P J Interferon Cytokine Res; 2004 Dec; 24(12):717-28. PubMed ID: 15684739 [TBL] [Abstract][Full Text] [Related]
18. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus. Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909 [TBL] [Abstract][Full Text] [Related]